Psychosomatic disorders: causes, development mechanisms, clinical manifestations and feasibilities of autopsychocorrection
https://doi.org/10.29235/1814-6023-2020-17-1-101-121
Abstract
The article reviews the information on the problem of psychosomatic disorders (PSDs) widespread in human population. Attention is drawn to the insufficient awareness of general practitioners in this field of pathology. The true-life situations are considered that the cause development of PSDs and the role of negative thoughts and an emotional factor in their development. A general scheme of the PSD pathogenesis is suggested, which is based on the shift in the balance of the excitation and inhibition processes in CNS towards the prevalence of the former ones. Suppression of the inhibitory processes results in the decrease of the excitation thresholds of different afferent systems and in the development of general hyperesthesia that causes the organism hyperreactivity to the external and internal actions, including the subthreshold ones and stimuli. This underlies the mechanism of PSD clinical manifestations. A possible role of CNS stagnant centers of excitement in the development of PSDs and their ability to migrate in the brain, which reflects the migration of PSD symptoms in the organism, are viewed. Mental, neurologic, cardiovascular, respiratory, digestive, urination, sexual and skin manifestations of PSDs are discussed. General approaches to treating PSD patients are considered. The fundamental importance of the mood factor in the PSD development and alleviation is substantiated.
About the Author
I. N. Semenenya
Institute of Biochemistry of Biologically Active Compounds of the National Academy of Sciences of Belarus
Belarus
Belarus
Igor N. Semenenya – D. Sc. (Med.), Professor, Director
50, BLK, 230030, Grodno
References
1. Comprehensive plan of action in mental health for the years 2013–2020. Available at: https://apps.who.int/iris/handle/10665/151502 (accessed 05.02.2015) (in Russian).
2. Andreeva M. F. Letters. Memoris. Articles. Documents. Мoscow, Iskusstvo Publ., 1968. 796 p. (in Russian).
3. Aleksander F. Psychosomatic medicine. Principles and practical application. Мoscow, EKSMO-Press Publ., 2002. 352 p. (in Russian).
4. Mostovaya L. I., Kuvshinova N. Y. Present-day views of psychosomatic disorders. Izvestiya Samarskogo nauchnogo tsentra Rossiiskoi akademii nauk [Proceedings of Samara Research Center of the Russian Academy of Sciences], 2011, vol. 13, no. 2–3, pp. 602–605 (in Russian).
5. Rodermel’ Т. А., Shumilova Е. А. Psychological view of causes of the origin of psychosomatic diseases. Mezhdunarodnyi zhurnal prikladnykh i fundamental’nykh issledovanii [International journal of applied and fundamental research], 2016, no. 8, pt. 2, pp. 180–184 (in Russian).
6. Topolyanskii V. D., Strukovskaya М. V. Psychosomatic Disorders. Мoscow, Meditsina Publ., 1986. 384 p. (in Russian).
7. Bennett A. E. Role of iatrogenesis in diagnosis, prognosis and treatment in psychiatry. Diseases of Nervous System, 1971, vol. 32, no. 9, pp. 627–631.
8. Sandomirskii М. Е. Psychosomatics and Bodily Psychotherapy. Мoscow, Nezavisimaya firma “Кlass”, 2005. 592 p. (in Russian).
9. Bobrov А. Е. Problem of psychosomatic relations and some methodological issues of psychopathology. Sotsial’naya i klinicheskaya psikhiatriya [Social and clinical psychiatry], 2017, vol. 27, no. 1, pp. 98–103 (in Russian).
10. Fusu L. I. Social and psychological aspects of psychosomatic disorders in patients with depression with concomitant addiction to drugs. Dnevnik Kazanskoi meditsinskoi shkoly [Dairy of Kazan medical school], 2017, no. 4, pp. 81–87 (in Russian).
11. McDougall J. Théâtres du corps: le psychosoma en psychanalyse. Paris, Gallimard, 1989. 220 p. (in French).
12. Pezeshkian N. Psychosomatics and Positive Psychotherapy. Мoscow, Institute of Positive Psychotherapy Publ., 2006. 464 p. (in Russian).
13. Symptoms and masks. Psychosomatic and somatopsychic disorders in children. XV Interdisciplinary Vein conference. Satellite symposium of the Materia Medica Company. Effektivnaya farmakoterapiya [Effective pharmacotherapy], 2019, vol. 15, no. 14, pp. 80–88 (in Russian).
14. Belyalov F. I. Psychosomatics. Мoscow, GEOTAR-Media Publ., 2018. 344 p. (in Russian).
15. Kulakov С. А. Fundamentals of psychosomatics. Sankt-Peterburg, Rech’ Publ., 2003. 288 p. (in Russian).
16. Starshenbaum G. V. Psychosomatics and psychotherapy: curing of the soul and the body. Мoscow, Institute of Psychotherapy Publishing House, 2005. 496 p. (in Russian).
17. Oppenheim H. Guide in nervous diseases for doctors and students. Berlin, S. Karger Publ., 1894. 870 p.
18. Khokhlov L. К. Debates of “psychics” and “somatics”. Evolution of views of psychosomatic to somatopsychic ratio. Sotsial’naya i klinicheskaya psikhiatriya [Social and clinical psychiatry], 2019, vol. 29, no. 2, pp. 79–85 (in Russian).
19. Sel’chenok К. V. Key to the future. Practical guide for user of arttechnological psychoprocessor. Мinsk, Kharvest Publ., 2004. 768 p. (in Russian).
20. Smirnov I. V., Beznosyuk Е. V., Zhuravlev А. N. Psychotechnologies. Computer psychosemantic analysis and psychocorrection at subconscious level. Мoscow, Progress–Kul’tura Publ., 1995. 416 p. (in Russian).
21. Latynin О. А. On the diagnosis and therapy of psychosomatic disorders. Tsentral’nyi nauchnyi vestnik [Central scientific bulletin], 2017, vol. 2, no. 3, pp. 30–34 (in Russian).
22. Mendelevich Е. G. Somatization of anxiety disorders in the practice of a neurologist: algorithms and approaches to differentiated treatment. Nevrologiya, neuropsikhiatriya, psikhosomatika [Neurology, neuropsychiatry, psichosomatics], 2014, no. 4, pp. 81–86 (in Russian).
23. Smulevich А. B. (ed.). Psychosomatic disorders in clinical practice. Мoscow, MEDpress-inform Publ., 2016. 776 p. (in Russian).
24. Chikurov Yu. V. Practical psychosomatics. Мoscow, Triada-X Publ., 2019. 185 p. (in Russian).
25. Starcevic V. The reappraisal of benzodiazepines in the treatment of anxiety and related disorders. Expert Review of Neurotherapeutics, 2014, vol. 14, no. 11, pp. 1275–1286. https://doi.org/10.1586/14737175.2014.963057
26. Linden M., Bandelow B., Boerner R. J., Brasser M., Kasper S., Möller H. J., Pyrkosch L., Volz H. P., Wittchen H. U. The best next drug in the course of generalized anxiety disorders: The “PN-GAD-algorithm”. International Journal of Psychiatry in Clinical Practice, 2013, vol. 17, no. 2, pp. 78–89. https://doi.org/10.3109/13651501.2012.722645
Review
For citations:
Semenenya I.N. Psychosomatic disorders: causes, development mechanisms, clinical manifestations and feasibilities of autopsychocorrection. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2020;17(1):101-121. (In Russ.) https://doi.org/10.29235/1814-6023-2020-17-1-101-121
Views: 981
Email this article 